[Skip to Navigation]
Views 330
Citations 0
Comment & Response
February 2017

Risk and Benefit Information and Use of Aspirin

Author Affiliations
  • 1Center for Chronic Care Innovation, HealthPartners Institute, Minneapolis, Minnesota
JAMA Intern Med. 2017;177(2):291. doi:10.1001/jamainternmed.2016.7988

To the Editor The Viewpoint by Drs Mora and Manson1 in a recent issue of JAMA Internal Medicine recognizes that aspirin use for primary prevention of atherosclerotic cardiovascular disease (ASCVD) needs to be highly individualized to accurately balance benefits and risks. They suggest a practical approach to aid clinicians with calculating ASCVD and bleeding risk using an app for mobile devices to facilitate patient discussion and shared decision making.1 While this could facilitate the benefit-risk assessment, the lack of integration of the app with the electronic health record and need for extensive data input are barriers to use in a busy primary care practice.

Add or change institution